PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug combination treats hepatitis C patients also infected with HIV

Novel treatment has 97 percent success rate in co-infected patients

2015-07-22
(Press-News.org) Roughly 20 to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both blood-borne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to adverse interactions with HIV treatments. Researchers at University of California, San Diego School of Medicine report a new combination that effectively treats HCV in patients co-infected with HIV.

The study, published online in the New England Journal of Medicine, found the combination of HCV drugs daclatasvir and sofosbuvir - both pills - cured HCV in 97 percent of patients also infected with HIV.

"In many HCV/HIV co-infected patients, HCV therapies can have a strong interaction with HIV medications that complicate or potentially exclude them from HCV treatment," said David Wyles, MD, lead author of the study in the Division of Infectious Diseases. "This study is novel because it shows the new drug combination was not compromised when used with a wide range of HIV medications, increasing the number of HCV/HIV patients who can be treated without modifying their HIV medications."

The 12-week study involved 151 patients and was the first to test this treatment regimen in those with HIV/HCV. Patients who participated in the clinical trial were closely monitored up to 24 weeks post treatment.

Another reason the study findings are important, said Wyles, is because HCV is a major cause of chronic liver disease in the United States, and liver damage progresses more rapidly in those also infected with HIV.

"Liver disease is a leading cause of death among HIV patients, so it is a high priority to treat co-infected patients and reduce the potentially fatal effect," said Wyles, also associate professor of medicine at UC San Diego School of Medicine.

Sofosbuvir is already approved for use in the United States; daclatasvir is scheduled to be reviewed by the Food and Drug Administration in August.

"These findings are very exciting in the infectious diseases world, as they could help an entire demographic that has historically struggled finally receive successful treatment for HCV," said Wyles.

INFORMATION:

Co-authors include Peter J. Ruane, MD, Ruane Medical and Liver Health Institute; Mark S. Sulkowski, MD, Johns Hopkins University, Lutherville, MD; Douglas Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York; Anne Luetkemeyer, MD, Los Angeles, the University of California, San Francisco, San Francisco; Timothy R. Morgan, MD, Veterans Affairs Long Beach Healthcare System, Long Beach; Kenneth E. Sherman, MD, PhD, University of Cincinnati College of Medicine, Cincinnati; Robin Dretler, MD, Infectious Disease Specialists of Atlanta, Decatur, GA; Dawn Fishbein, MD, MedStar Washington Hospital Center; Joseph C. Gathe, Jr., MD, the Cure C Consortium, Houston; Sarah Henn, MD, Whitman-Walker Health; Federico Hinestrosa, MD, Orlando Immunology Center, Orlando; Charles Huynh, DO, the Jeffrey Goodman Clinic, Los Angeles LGBT Center; Cheryl McDonald, MD, Tarrant County Infectious Disease Associates, Fort Worth; Anthony Mills, MD, Southern California Men's Medical Group-Men's Health Foundation; Edgar Turner Overton, MD, the University of Alabama at Birmingham, Birmingham; Moti Ramgopal, MD, Midway Immunology and Research Center, Fort Pierce; Bruce Rashbaum, MD, Capital Medical Associates; Graham Ray, MSN, ANP, the University of Colorado, Denver; Anthony Scarsella, MD, Pacific Oaks Medical Group, Beverly Hills; Joseph Yozviak, DO, Lehigh Valley Health Network, Allentown, PA; Fiona McPhee, PhD, Philip D. Yin, MD, PhD, Peter Ackerman, MD - all with Bristol-Myers Squibb, Wallingford, CT; Eric Hughes, MD, PhD, Stephanie Noviello, MD Zhaohui Liu, PhD - all with Princeton, NJ.

Funding for this research came, in part, from Bristol Myers Squibb.



ELSE PRESS RELEASES FROM THIS DATE:

Low-nicotine cigarettes fail to sway smokers

2015-07-22
Smokers who successfully lowered their nicotine intake when they were switched to low-nicotine cigarettes were unable to curb their smoking habits in the long term, according to a study by researchers at UCSF and San Francisco General Hospital and Trauma Center. The study, published online today (July 22) in the journal Addiction found that levels of cotinine, a derivative of nicotine measured in the blood, plummeted six months after smokers' regular cigarettes were replaced with low-nicotine ones. But levels started to rebound later into the study when smokers returned ...

Hair ice mystery solved

Hair ice mystery solved
2015-07-22
You may have never seen or heard of it, but hair ice - a type of ice that has the shape of fine, silky hairs and resembles white candy floss - is remarkable. It grows on the rotten branches of certain trees when the weather conditions are just right, usually during humid winter nights when the air temperature drops slightly below 0°C. Now, a team of scientists in Germany and Switzerland have identified the missing ingredient that gives hair ice its peculiar shape: the fungus Exidiopsis effusa. The research is published today (22 July) in Biogeosciences, an open access ...

Having wealthy neighbors may skew beliefs about overall wealth distribution

2015-07-22
Wealthy people may be likely to oppose redistribution of wealth because they have biased information about how wealthy most people actually are, according to new research published in Psychological Science, a journal of the Association for Psychological Science. The findings indicate that people use their own neighborhoods and communities as a gauge of how much wealth other people possess, leading wealthy people to perceive the broader population as being wealthier than it actually is. "If you're rich, there's a good chance you know lots of other rich people and relatively ...

Current dietary protein recommendations need updating

2015-07-22
New research based on modern techniques suggests that recommendations for protein intake in healthy populations may be incorrect. In a paper just published in Applied Physiology, Nutrition, and Metabolism, an NRC Research Press journal (a division of Canadian Science Publishing), researchers put the focus on protein as an essential component of a healthy diet. Protein helps people stay full longer, preserve muscle mass, and when combined with adequate physical activity, has the potential to serve as a key nutrient for important health outcomes and benefits. It's not ...

New evidence of cultural diversification between neighboring chimpanzee communities

New evidence of cultural diversification between neighboring chimpanzee communities
2015-07-22
For centuries it has been thought that culture is what distinguishes humans from other animals, but over the past decade this idea has been repeatedly called into question. Cultural variation has been identified in a growing number of species in recent years, ranging from primates to cetaceans. Chimpanzees, our closest living relatives, show the most diverse cultures aside from humans, most notably, in their use of a wide variety of tools. The method traditionally used to establish the presence of culture in wild animals compares behavioural variation across populations ...

A dictionary of the language of cells

2015-07-22
In their struggle to survive and prosper, multicellular organisms rely on a complex network of communication between cells, which in humans are believed to number about 40 trillion. Now, in a study published in Nature Communications, a research group led by scientists from the RIKEN Center for Life Science Technologies (CLST) has published an overall map of how the cells in the human body communicate by systematically analyzing the relationship between ligands--substances such as insulin and interferon that embody messages between cells, and receptors--the proteins on cell ...

Targeting the strain of bacteria that causes ulcers may help prevent stomach cancer

2015-07-22
A new review published in the Cochrane Library, indicates that eradicating Helicobacter pylori bacterium-- the main cause of stomach ulcers - with a short course of therapy comprising two commonly used medicines may help to reduce the risk of gastric cancer. Stomach, or gastric, cancer is the third most common cause of death from cancer worldwide, and people who are infected with the Helicobacter pylori bacterium are more likely to develop the disease. About two-thirds of us have H. pylori in our bodies, but in most cases we experience no discomfort or other symptoms. ...

Progressively reducing the nicotine content of cigarettes may not lead smokers to quit

2015-07-22
The US Family Smoking Prevention and Tobacco Control Act, passed in 2009, permits the U.S. Food and Drug Administration (FDA) to set standards for cigarette nicotine content. The FDA is accordingly supporting research into how very low nicotine content (VLNC) cigarettes might function as a regulatory measure to make cigarettes non-addictive, reduce smoke exposure, and improve public health, even among people who don't want to quit smoking. New research published today in the scientific journal Addiction shows that simply reducing the nicotine content of cigarettes may ...

HIV treatment has social and socioeconomic benefits, as well as improved health: Study

2015-07-22
New research shows that HIV treatment for illicit drug users improves their social and socioeconomic wellbeing as well as their health. While the health benefits of antiretroviral therapy (ART) for HIV are well documented, less is known about possible secondary benefits. Lindsey Richardson, an assistant professor in the Department of Sociology at the University of British Columbia and research scientist with the BC Centre for Excellence in HIV/AIDS (BC-CfE), presented findings from two studies July 22 at the International AIDS Society (IAS) Conference in Vancouver. ...

Selfishness lasts a lifetime, according to mongoose study

Selfishness lasts a lifetime, according to mongoose study
2015-07-22
Researchers studying wild banded mongooses in Uganda have discovered that these small mammals have either cooperative or selfish personalities which last for their entire lifetime. The findings of the 15-year study are published today in the journal Animal Behaviour. The researchers investigated the selfish behaviour of mongoose mate-guarding - where dominant males guard particular females - and the cooperative behaviour of 'babysitting' and 'escorting' the young. They found that cooperative mongooses that helped out with offspring care did so consistently over their ...

LAST 30 PRESS RELEASES:

Deep-learning framework advances tissue analysis in spatial transcriptomics

From dormant to danger: How VZV reactivation is driving CNS infections

DNA barcodes narrow down possible sources of introductions of an invasive banana skipper butterfly pest

Transforming clinical care for children with rare genetic diseases

Polar bear cubs emerging from their dens for the first time: New study captures rare footage

Turning waste organic compound into useful pharmaceuticals and energy using a technique inspired by photosynthesis

Violence alters human genes for generations, researchers discover

Scientists discover key protein in resilience to stress

Nasal spray shows preclinical promise for treating traumatic brain injury

Cambridge initiative to address risks of future engineered pandemics

Unmasking inequalities in AI: new research reveals how artificial intelligence might reinforce inequality

Taking sports science in her stride: How Dr. Nerea Casal García aims to maximize performance on the track

Pioneering work generates feline embryonic stem cells in boon for cats

Decoding the link between colorectal cancer risk and steatotic liver disease

Controlling conformational changes in protein aromatic side chains

Experimental and numerical analysis of the potential drop method for defects caused by dynamic loads

Chinese researchers make breakthrough in artificial chiral structural-color microdomes

Intermittent fasting inhibits platelet activation to reduce thrombosis risk

A clear game-changer: Curtin’s water-repellent glass breaks new ground

Are our refrigerants safe? The lingering questions about the chemicals keeping us cool

How nitrogen reshapes root system architecture in plants?

‘Fluorescent phoenix’ discovered with persistence rivaling Marie Curie’s

A rapid and reproducible method for generating germ-free Drosophila melanogaster

Aging and the brain’s sugar-coated shield

Better poverty mapping: New machine-learning approach targets aid more effectively

An emissions tale of two cities: Salt Lake City vs. Los Angeles

WVU nursing faculty aim to enhance rural home care for chronically ill through NIH award

New screening tool for stroke survivors with visual perception problems

Influencer marketing can help tourism industry mitigate waste, pollution

Tufts named a top producer of U.S. Fulbright students

[Press-News.org] New drug combination treats hepatitis C patients also infected with HIV
Novel treatment has 97 percent success rate in co-infected patients